Revenue segments as reported by the company.

Gaming

Professional Visualization

Datacenter

Auto

OEM & IP

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Acquisition termination cost

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Cash & Short Term Investments

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

NVIDIA

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU), Tegra Processor, and All Other. The GPU segment comprises of product brands, which aims specialized markets including GeForce for gamers; Quadro for designers; Tesla and DGX for AI data scientists and big data researchers; and GRID for cloud-based visual computing users. The Tegra Processor segment integrates an entire computer onto a single chip, and incorporates GPUs and multi-core CPUs to drive supercomputing for autonomous robots, drones, and cars, as well as for consoles and mobile gaming and entertainment devices. The All Other segment refers to the stock-based compensation expense, corporate infrastructure and support costs, acquisition-related costs, legal settlement costs, and other non-recurring charges. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in January 1993 and is headquartered in Santa Clara, CA.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

NVDA reports record data center revenue and outlines AI opportunities

NVDA's Q1 2023 earnings call showcased strong performance, particularly in data center revenue and gross margins. While the company faces challenges in supply chain support and competitive landscape, opportunities in accelerated computing and generative AI are key focus areas for future growth.

NVIDIA reports record Q2 revenue, faces regulatory challenges in China

NVIDIA's Q2 performance reflects robust revenue growth, particularly in the Data Center, Gaming, and AI segments. While facing potential regulatory challenges and supply constraints, the company's strategic partnerships and focus on accelerated computing and generative AI position it for continued success and expansion.

NVIDIA achieves record Q3 revenue, navigates export challenges for growth

NVIDIA's Q3 showcased robust performance in data center, gaming, and ProViz segments, while facing challenges from export control regulations. The company is actively pursuing opportunities in new markets and deepening collaborations to drive future growth.

NVIDIA reports steady Q4 revenue growth, eyes AI infrastructure expansion

NVIDIA delivered solid Q4 results with revenue growth across key segments, showcasing resilience and market strength.
The company faces challenges in managing rising expenses and sustaining growth momentum amidst market dynamics and technological shifts.
However, NVIDIA's strategic partnerships, innovative offerings, and outlook for future growth position it well to capitalize on expanding opportunities.
By focusing on AI infrastructure, cloud services, and cutting-edge technologies, NVIDIA remains at the forefront of driving industry transformation and innovation.

NVIDIA reports robust Q1 earnings, eyes growth in generative AI

NVIDIA's Q1 performance showcased strong revenue growth, particularly in data center and gaming segments.
The company's focus on accelerated computing, generative AI, and software offerings underpins its competitive edge.
While facing market challenges, NVIDIA is well-positioned to capitalize on opportunities in AI workloads and architecture partnerships.

NVIDIA reports record Q2 revenue, eyes growth in AI technologies

NVIDIA's Q2 performance reflects robust growth across key segments, underpinned by strong revenue, strategic partnerships, and a focus on transformative technologies.
While facing challenges like potential export regulations and fluctuating automotive revenue, NVIDIA is well-positioned to leverage opportunities in accelerated computing, AI, and software integration.
The company's emphasis on innovation, collaboration, and market expansion sets the stage for continued success, with Q3 revenue outlook and product demand indicating a positive trajectory for NVIDIA.
By navigating challenges, capitalizing on opportunities, and leveraging strengths in technology and partnerships, NVIDIA remains at the forefront of driving growth and innovation in the semiconductor industry.

NVIDIA reports record Q3 revenue, eyes data center growth

NVIDIA's Q3 performance reflects robust revenue growth across key segments, driven by strong demand and innovative product offerings.
While facing challenges from export regulations and seasonality, the company's strategic strengths in technology, partnerships, and operational efficiency position it well for future growth.
With a focus on expanding data center opportunities, advancing AI capabilities, and navigating regulatory complexities, NVIDIA is poised to capitalize on industry trends and drive continued success.

NVIDIA reports record Q4 earnings, eyes AI growth opportunities

NVIDIA's Q4 2024 was exceptional, driven by record revenue, particularly in Data Center and Gaming segments.
Despite challenges like U.S. government restrictions, NVIDIA is adapting and focusing on accelerated computing and generative AI.
The company's strong software business, collaborations, and strategic positioning in AI offer promising growth opportunities.
With a robust outlook for fiscal year 2025 and a focus on AI-centric industries, NVIDIA is poised for continued success and innovation.

NVIDIA reports record Q1 revenue, eyes sustained growth opportunities

NVIDIA's Q1 performance reflects robust revenue growth across key segments, showcasing market acceptance and strong positioning.
While facing supply constraints and future innovation challenges, NVIDIA's technology leadership and partnerships position them for sustained growth.
Opportunities in expanding sectors and advancements in chip design and networking technology offer avenues for future growth and differentiation.

NVIDIA reports record Q2 revenue, eyes growth with AI focus

NVIDIA's Q2 2025 earnings call showcased exceptional revenue growth across key segments, driven by strong Data Center and Gaming performance.
The company's focus on generative AI, accelerated computing, and upcoming Blackwell platform positions it well for future growth.
While facing margin variability and integration challenges, NVIDIA's strategic emphasis on AI technologies presents significant revenue opportunities.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

Recursion Pharmaceuticals

Nvidia is investing $50 million in Recursion Pharmaceuticals. The two companies are also working together to use AI to speed up drug discovery.

Why Recursion Pharmaceuticals Stock Is Skyrocketing This Week (Hint: Thanks, Nvidia)

Advanced Micro Devices

Amazon

Alphabet

Intel

Microsoft

Oracle

“AI” may be the two most frequently spoken letters in the business world this year, but the technology is not as high a priority as one might think when it comes to where executives are planning to spend their money on cloud services over the next two years.

AI is driving big gains in tech — but it is not as great a factor in cloud spending

Recursion Pharmaceuticals (NASDAQ: RXRX ) stock is the talk of Wall Street lately. Indeed, RXRX soared more than 120% Wednesday after Nvidia (NASDAQ: NVDA ) announced it would invest $50 million into the biotech firm to use artificial intelligence (AI) for drug discovery.

Did Nvidia Make Recursion Pharmaceuticals (RXRX) Stock the Next AI Play?

NXP Semiconductors

Semiconductors devices are crucial to the modern digital economy. These tiny electronics power everything from our smartphones and personal computers to cars, commercial airplanes and cloud servers.

3 Semiconductor Stocks That AI Is Loving in July

YieldMax NVDA Option Income Strategy ETF is a single-stock based fund that generates yields from selling options in Nvidia Corporation stock, with an annualized yield of 48% so far. The fund uses a three-step options strategy and is actively managed, adjusting its holdings based on how Nvidia stock acts, and has outperformed the S&P 500 by about 200% since its launch. The fund is a good investment for those who are bullish or neutral on Nvidia, but not for those who are bearish on the stock due to potential large losses if the stock value drops.

NVDY: Generating 50% Yield From Nvidia Options

Nvidia (NVDA) is reportedly making a move again to invest in the U.K.-based chipmaker Arm.

NVIDIA (NVDA) Stock Up 3.5% on Report of Investing in Arm

Apple

Tesla

A "special rebalance" is coming to the Nasdaq 100 and related ETFs. But right now, only the six largest stocks will be most affected.

'Super 6' Stocks Feel The Heat From Big Nasdaq 100 Crackdown

Microchip Technology

ON Semiconductor

The semiconductor industry is rebounding which is helping stocks like NVIDIA Corporation (NVDA), Intel Corporation (INTC), Microchip Technology (MCHP), ON Semiconductor Corporation (ON), NXP Semiconductors (NXPI).

5 Solid Semiconductor Stocks to Buy on Rebounding Chip Sales (Revised)

C3.ai

C3.ai is growing slowly, and it's unclear how successful the company will be in converting pilot customers. Nvidia is seeing booming demand for its AI chips, but the company is now valued at over $1 trillion.

Warning: These 2 Hot AI Stocks Are Too Risky

Taiwan Semiconductor Manufacturing

Artificial intelligence software is driving increasing demand for semiconductors.

Best AI Stocks to Buy: Nvidia vs. Taiwan Semiconductor

Tech giant NVIDIA Corporation (NASDAQ:NVDA) has dedicated US$50mln to a multi-year collaboration with US-listed biotech company Recursion Pharmaceuticals to develop AI-based software for improving patient treatments.  Recursion also announced plans to accelerate the development of its AI foundation models for biology and chemistry, which, in collaboration with NVIDIA, it intends to optimise and distribute to biotechnology companies using NVIDIA cloud services.

Nvidia and Recursion Pharmaceuticals team up on AI-based biotech collaboration

Nvidia's investment in Recursion caused its stock price to jump dramatically on Tuesday.

Nvidia Just Invested in This Pharmaceutical Company, Causing Its Stock Price to Skyrocket

Broadcom

Everyone knows that AI stocks have been the big momentum trade in the first half of 2023. The question is, can it remain the momentum trade in the second half of the year?

3 AI Stocks to Catapult You into the Millionaires' Club

Confirming the ongoing fervor for all things artificial intelligence (AI), shares of biotechnology firm Recursion Pharmaceuticals (NASDAQ: RXRX ) are soaring on Wednesday. What has catalyzed the massive double-digit swing for RXRX stock?

RXRX Stock: Nvidia Investment Sends Recursion Pharmaceuticals Soaring

Recursion Pharmaceuticals stock soared as much as 121% on Wednesday after it received an investment from Nvidia. Nvidia said it would invest $50 million in the company as it works to use AI for drug discovery.

Recursion Pharmaceuticals soars 121% after Nvidia invests $50 million in the biotech for AI drug discovery

Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners, including Roche and Bayer.

Nvidia invests $50 million in biotech company Recursion for AI drug discovery

Micron Technology

Palantir Technologies

Direxion Daily Semiconductor Bull 3x Shares

We end each quarter by reviewing our work within the semi and software/hardware spaces, analyzing our best calls and where we could've done better. This quarter was exceptional; we launched our Investing Group, Nvidia Corporation triggered the A.I. rally carrying Advanced Micro Devices, Inc., Marvell Technology, Inc., Broadcom Inc., and others higher on A.I. fumes. The market is in a deadlock, with the Fed expecting interest rates to move higher.

Back To The Future 4.0 - Reviewing Our Calls For Q2

The changes of a “special rebalance” of the Nasdaq 100 are set to be announced on July 14 as part of an effort to reduce the dominance of the index's seven most major tech stocks, referred to as the “Magnificent Seven.” Indeed, some of the index's most elite tech companies are set to have their weight significantly reduced as part of an effort to mitigate over-concentration of some companies in the index.

7 Tech Stocks to Watch on July 14

Nvidia shares rose following reports that it's in talks with Britain's Arm about a U.S. IPO.

Nvidia Shares Advance After Report of Talks With Arm on US IPO

Recursion Pharmaceuticals Inc. RXRX, +75.96% shares soared Wednesday after the drug developer said that graphics processing unit maker Nvidia Corp. NVDA, +2.54% invested $50 million in the company to boost drug discovery efforts using artificial intelligence. Recursion shares surged as much as 120% to an intraday high of $14.99, and were last up 64% at $11.11 in morning trading.

Recursion Pharmaceuticals stock soars following $50 million investment from AI chipmaker Nvidia

Recursion Pharmaceuticals Inc shares surged 64% to $11.09 in late-morning trading on Wednesday after NVIDIA Corp announced it is making a $50 million investment to accelerate training of the biotech company's artificial intelligence (AI) models for drug discovery. Recursion stated that it will train AI models on NVIDIA's cloud platform using its own biological and chemical datasets exceeding 23,000 terabytes, which it can then potentially license out to biotech firms via BioNeMo, a generative AI cloud service for drug discovery that NVIDIA launched earlier this year, Reuters reported.

Recursion Pharmaceuticals stock soars on NVIDIA investment in AI

Nvidia is in discussions to acquire a stake in UK-based chip designer Arm before it goes public.  A stake in Arm will complement Nvidia's competencies as the world's top chipmaker, as it rides the AI boom.

Nvidia is looking to expand its silicon empire as it rides the AI boom - the chipmaker is in discussions for a stake in the UK's Arm

Recursion snagged a $50 million investment from Nvidia on Wednesday to work on drug development using AI, and RXRX stock nearly doubled.

Recursion Catapults 70% On Nvidia Investment For AI In Drug Development

Pinterest

Artificial Intelligence (AI) has received incredible attention this year due to the release of OpenAI's advanced chatbot, ChatGPT.  Since its advent, ChatGPT has fortunately not been the only chatbot to be released.

3 Machine Learning Stocks That AI Is Loving in July

Recursion Pharmaceuticals stock has gained more than 150%.

News for NVIDIA Stock (NVDA)